Skip to main content

Sara McDonough, MSN, RN, CRNP-AC

Sara McDonough, MSN, RN, CRNP-AC

Sara McDonough, MSN, RN, CRNP-AC

(She/Her)

Sara McDonough, MSN, RN, CRNP-AC, is a nurse practitioner with the Cancer Center at Children's Hospital of Philadelphia.

Areas of expertise: Pediatric oncology, Hematologic malignancies, Lymphoma, Leukemia

Locations: Buerger Center for Advanced Pediatric Care


215-590-3025

267-426-0762

About Sara McDonough, MSN, RN, CRNP-AC

Titles

Hematologic Malignancies Outpatient Nurse Practitioner 

Certifications

Certified Registered Nurse Practitioner - Acute Care (CRNP-AC)

Basic Life Support (BLS)

Pediatric Advanced Life Support (PALS)

NCI-CTEP Non-Physician Investigator (NPIVR)

Human Subjects Research (HSR) Protections Biomedical Research – Collaborative Institutional Training Initiative (CITI)

Good Clinical Practice (GCP) – Collaborative Institutional Training Initiative (CITI)

Awards and Honors

2025, Preceptor of the Year for the Pediatric Acute Care Nurse Practitioner Program, University of Pennsylvania
2023, Fellow Appreciation Award: Oncology Team Member
2023, APP Clinician Award Nominee
2023, Extra Mile Award Nominee
2022, APP Advancement Program Clinical Leader Expert Achievement Award
2022, Alexandra Scott Pitcher of Hope Award Nominee

Education & training

Undergraduate Degree

BSN - University of Pennsylvania, School of Nursing, Philadelphia, PA
BS in Human Science with a Minor in Psychology - Georgetown University, School of Nursing and Health Studies, Washington DC

Graduate Degree

MSN, Pediatric Acute/Chronic-Oncology Nurse Practitioner Program - University of Pennsylvania, School of Nursing, Philadelphia, PA

Team affiliations

View fewer team affiliations View all team affiliations

Publications

Publications

2024

Pollock, C.B., McDonough, S., Wang, V.S., Lee, H., Ringer, L., Li, X., Prandi, C., Lee, R.J., Feldman, A.S., Koltai, H., Kapulnik, Y., Rodriguez, O.C., Schlegel, R., Albanese, C., & Yarden, R.I. (2014). Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogramed primary prostate cancer cells. Oncotarget, 5(6), 1683-1698.

2023

Spear, T.S., Oranges, K., McDonough, S., Ma, Y., Gerace,C., Phillips, C.A., Rheingold, S.R. (2023). A Real-World, Single Institution, Post-Market Comparison of Pegaspargase and Calasparagase Pegol-Mknl Therapeutic Drug Monitoring and Toxicity. Blood, 142(1 Suppl.), 128.

Abstracts (includes Posters and Scientific Presentations)

2025

Burns-Lynch, P., Weaver, A., McDonough, S., Oranges, K., Gillespie, M., Kocent, L. Decreasing CLABSIs with Standardized Blinatumomab Education; Poster session accepted for presentation at: Association of Pediatric Hematology/Oncology Nurses National Conference; 2025 September 25-57; Providence, Rhode Island.

Jump back to top